Evidence map›Paper›PMID 38926343›Full record

ArticleNature communications2024

Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints.

Ethan C Veit, Madihah S Salim, Mariel J Jung, R Blake Richardson, Ian N Boys, Meghan Quinlan, Erika A Barrall, Eva Bednarski, Rachael E Hamilton, Caroline Kikawa and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Innate Immune and Inflammatory Responses to Dengue Virus Infection.Current topics in microbiology and immunology · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ethan C VeitDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3956-5928
Madihah S SalimDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mariel J JungDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
R Blake RichardsonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ian N BoysDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Meghan QuinlanDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Erika A BarrallDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Eva BednarskiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rachael E HamiltonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Caroline KikawaMedical Scientist Training Program, University of Washington, Seattle, WA, USA.
Nels C EldeDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-0426-1377
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-6551-1827
Matthew J EvansDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. matthew.evans@mssm.edu.ORCID 0000-0002-4991-3877

Funding

TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Zika virus nonstructural protein 5 inhibition of interferon signalingR01AI175303 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Matthew J Evans, Adolfo Garcia-Sastre · 2023 to 2026
$3.3M
Viral Pathogenesis Training ProgramT32AI083203 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D, LAGUNOFF, MICHAEL · 2009 to 2023
$2.7M
Evolutionary innovations from host-microbe interactionsR35GM134936 · NIGMS · UNIVERSITY OF UTAH · PI ELDE, NELS C. · 2020 to 2024
$1.7M
NIAID NIH HHS R01 AI175303NIAID NIH HHS T32 AI007647NIAID NIH HHS T32 AI083203NIGMS NIH HHS R35 GM134936U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI007647U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI083203U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM134936
6 · The paper itself

Abstract

Zika and dengue virus nonstructural protein 5 antagonism of STAT2, a critical interferon signaling transcription factor, to suppress the host interferon response is required for viremia and pathogenesis in a vertebrate host. This affects viral species tropism, as mouse STAT2 resistance renders only immunocompromised or humanized STAT2 mice infectable. Here, we explore how STAT2 evolution impacts antagonism. By measuring the susceptibility of 38 diverse STAT2 proteins, we demonstrate that resistance arose numerous times in mammalian evolution. In four species, resistance requires distinct sets of multiple amino acid changes that often individually disrupt STAT2 signaling. This reflects an evolutionary ridge where progressive resistance is balanced by the need to maintain STAT2 function. Furthermore, resistance may come with a fitness cost, as resistance that arose early in lemur evolution was subsequently lost in some lemur lineages. These findings underscore that while it is possible to evolve resistance to antagonism, complex evolutionary trajectories are required to avoid detrimental host fitness consequences.

Indexed as

Evolution, MolecularSTAT2 Transcription FactorViral Nonstructural ProteinsAnimalsDengue VirusFlavivirusHost-Pathogen InteractionsHumansMicePhylogenyZika VirusNS5 protein, dengue virusNS5 protein, flavivirusSTAT2 protein, humanSTAT2 Transcription FactorViral Nonstructural Proteins

Identifiers

PMID38926343
PMCPMC11208600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.